Evidence-Based Alternative Approaches to Migraine Prevention in Children: Riboflavin, Magnesium, Coenzyme Q10, Vitamin D, Feverfew, and Butterbur
Migraine is a common neurological condition in children, often resulting in significant morbidity and impaired quality of life. Traditional pharmacological treatments are widely used, but there is increasing interest in complementary and alternative approaches. This article reviews evidence supporting the use of riboflavin, magnesium, coenzyme Q10 (CoQ10), feverfew, and butterbur for preventing migraines in pediatric patients.
Summary of Evidence for Riboflavin in Pediatric Migraine
Riboflavin (Vitamin B2) has emerged as a potential preventive treatment for migraines, including in pediatric populations. Here’s a summary of the current evidence regarding its efficacy and safety for treating migraines in children:
- Riboflavin is essential for mitochondrial energy production, and its supplementation may enhance cellular energy metabolism. This is particularly relevant in migraine management, as mitochondrial dysfunction has been implicated in migraine pathophysiology.
- Talebian et al. (2018): Conducted a randomized, double-blind, placebo-controlled trial that found that high dose riboflavin supplementation (200 mg/day) significantly reduced migraine frequency and duration in children ages 5-13 years of age compared to lose dose (100mg/day) or placebo.
- Yamanaka et al. (2021): This narrative literature review looks at the effectiveness of dietary supplements for prophylactic pediatric migraine treatment. The authors concluded that upon review of the research, riboflavin, even at lower doses (25 or 100 mg), could have pharmacological effects in children, potentially alleviating migraine symptoms related to mitochondrial dysfunction.
- Condò et al. (2009): Retrospective study reported that riboflavin (200 or 400 mg daily) significantly reduced migraine frequency and intensity in a pediatric cohort.
- Athaillah et al(2012):Randomized, double-blind, placebo-controlled trial showed Riboflavin(400mg) effectively decreased migraine frequency, duration and disability in adolescents after 3 months of treatment.
- Das et al (2021): Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent patients concluded that riboflavin can reduce headache frequency, use of acute medications, and days of missed school. Riboflavin also reduced migraine intensity and duration.
- Maclennan et al. (2008):This randomized double-blind study showed no difference between the Riboflavin treatment group (200mg/day) and placebo.
- Bruijn J et al (2010): This placebo-controlled, randomized, double-blind, cross-over trial showed migraine headache frequency was not statistically different between medium dose riboflavin (50mg) and placebo in pediatric patients.
Riboflavin is generally well-tolerated, with few reported adverse effects. The most common side effect is a bright yellow discoloration of urine, which is harmless. Gastrointestinal symptoms have also been reported. Due to its low-risk profile, riboflavin is often favored as a preventive option for migraines in children.
Riboflavin shows promise as a preventive treatment for migraines in children, supported by emerging evidence indicating its efficacy and safety. Further research, particularly larger-scale studies focusing on pediatric patients, is needed to confirm these findings and establish optimal dosing strategies.
- When discussing riboflavin (vitamin B2) as a potential preventive treatment for migraines in pediatric patients, pediatricians should address the following points with parents:
- Overview of Riboflavin: Riboflavin is a vitamin that plays a role in energy metabolism and is thought to help reduce the frequency of migraines. Some studies suggest it may be effective, while others show mixed results.
- Safety Profile: Riboflavin is considered safe, with minimal side effects. This excellent safety profile makes it a suitable option for families seeking nonpharmacologic approaches to migraine management.
- Evidence: Mixed– While some research indicates potential benefits in reducing migraine frequency, the evidence is not uniform. Pediatricians should emphasize that results can vary from child to child.
- Risks vs Benefits: For families preferring to explore non-drug options first, trying riboflavin can be a reasonable choice. The potential benefits may outweigh the risks, especially given its low likelihood of adverse effects.
- Monitoring and Follow-Up: If parents decide to try riboflavin, it’s important to monitor the child’s response and maintain open communication about any changes in migraine patterns or side effects.
Summary of Evidence for Magnesium in Pediatric Migraine
Magnesium is an essential mineral that has garnered attention for its potential role in preventing migraines, including in pediatric populations. Here’s a summary of the current evidence regarding its efficacy and safety for treating migraines in children:
Magnesium plays a critical role in various physiological processes, including neurotransmitter release and vascular function. It is believed to help stabilize neuronal membranes and modulate pain perception, making it relevant in the context of migraine management.
- Gallelli et al. (2014): This clinical trial looked at children ages 5 to 16 with at least 4 migraines a month. They set out to determine prophylactic magnesium’s effect on Ibuprofen and Acetaminophen. This study concluded that the efficacy of Ibuprofen and Acetaminophen was increased in pediatric patients receiving prophylactic magnesium.
- Wang F et al.(2003): This randomized, double-blind, placebo-controlled pediatric trial set out to determine if magnesium oxide reduces migrainous headache frequency, severity and associated features compared to placebo. This study did not unequivocally determine whether oral Mg Oxide was superior to placebo in preventing frequent migraines in children, however treatment with Mag Oxide did show a significant improvement in headache severity.
- Kovačević et al. (2017): This study looked at disability levels, quality of life, and anxiety and depressive symptoms change after 6 months of magnesium prophylaxis in pediatric migraine. Magnesium prophylaxis significantly decreased migraine disability, improved physical and psychosocial well-being, and reduced anxiety and depressive symptoms in children aged 7-17 years.
- Teigen & Boes (2015): This is an evidence-based review of 16 studies from 1990 to 2015 looking at magnesium for the prevention of migraine. The authors highlighted that while magnesium supplementation is often recommended, the evidence supporting its efficacy in migraine prevention remains inconclusive, necessitating further investigation.
- Orr (2016):This evidence based review gives an overview of diet and nutraceutical interventions for headache management. With regard to the use of magnesium for pediatric migraine prophylaxis, the author concludes that the balance of evidence seems to be in favor of oral magnesium for migraine prophylaxis but more research is needed.
Magnesium is generally well-tolerated, with few adverse effects reported. The most common side effects are gastrointestinal, such as diarrhea, particularly at higher doses. Caution should be taken in children with kidney issues, as impaired kidney function can affect magnesium excretion and increase the risk of hypermagnesemia. Overall, magnesium has a favorable safety profile, making it a suitable option for pediatric patients.
The research on magnesium for pediatric migraine prevention presents a promising outlook, particularly in reducing the frequency and severity of migraines in some children. Several studies support its efficacy, especially in those with low magnesium levels. However, contradictory findings indicate that magnesium may not be effective for all pediatric patients, suggesting the need for individualized treatment approaches. Further research is warranted to clarify the optimal dosing and to better understand the variability in response among children.
- When discussing magnesium as a potential preventive treatment for migraines in pediatric patients, pediatricians should cover the following points with parents:
- Overview of Magnesium: Magnesium is a mineral that plays a crucial role in many bodily functions, including nerve function and muscle contraction. Some studies suggest it may help reduce the frequency and severity of migraines in children.
- Safety Profile: Magnesium has an excellent safety profile, especially when taken in appropriate doses. Most children tolerate it well, with minimal risk of side effects.
- Evidence: Mixed- While some research supports the use of magnesium for migraine prevention, other studies show inconclusive results. It’s important for parents to understand that effectiveness can vary among individuals.
- Benefit vs Risks: For families interested in exploring non-drug options first, trying magnesium can be a reasonable choice. Given its safety profile, the potential benefits may outweigh the risks for many children.
- Monitoring and Follow-Up: If parents decide to proceed with magnesium supplementation, ongoing monitoring of the child’s migraine patterns and any potential side effects is essential. Open communication about the child’s progress is key.
Summary of Evidence for Coenzyme Q10 in Pediatric Migraine
Coenzyme Q10 (CoQ10) is a naturally occurring antioxidant that has been investigated for its potential role in preventing migraines, including in pediatric populations. Here’s a summary of the current evidence regarding its efficacy and safety for treating migraines in children:
CoQ10 is vital for mitochondrial energy production and has antioxidant properties. Its supplementation may help improve cellular energy metabolism and reduce oxidative stress, both of which are believed to play a role in migraine pathophysiology.
- Yaghini et al., (2022): This RCT showed that CoQ10 might be effective in lowering the duration, frequency, and severity of migraines in children. Its therapeutic effect was similar to that of Amitryptyline. CoQ10 may be an effective prophylactic treatment for pediatric migraines but larger RCTs are needed.
- Orr (2016): This evidence based review looked at 30 studies, both observational studies and RCTs, on the efficacy of nutraceuticals for pediatric migraine. Overall, they concluded that the evidence is poor however did note there was weak evidence for the use of Magnesium, CoQ10, and Petadolex. The authors recommended their use for pediatric migraine prophylaxis.
- Gaul et al. (2015): This randomized, placebo-controlled trial found that a proprietary supplement containing CoQ10, riboflavin, and magnesium improved migraine pain and burden of disease in adult participants. Patients rated the efficacy of treatment significantly superior to placebo.
- Hershey et al., (2007): This study looked at pediatric patients with frequent headaches and assessed them for CoEnzyme Q deficiency. 32.9% of patients had low CoEnzyme Q level and began supplementation. With increasing CoEnzyme Q levels, headache frequency and headache disability improved significantly. The authors concluded that CoEnzyme Q deficiency may be common in pediatric and adolescent patients with migraine.
- Slater et al. (2011): Performed a randomized, double-blinded, placebo-controlled crossover study of CoQ10 in the prevention of pediatric and adolescent migraines. Participants reported improvement within the first 4 weeks of initiation. After the initial stage, no statistically significant improvement was noted however almost half the participants dropped out of the study after the initial phase. The authors speculated that the high drop-out rate was due to rapid improvement associated with CoEnzyme Q. This likely affected the final results.
CoQ10 is generally well-tolerated, with few reported side effects. The most common adverse effects include gastrointestinal discomfort, which tends to be mild. Its favorable safety profile makes CoQ10 an appealing option for pediatric patients.
When discussing coenzyme Q10 (CoQ10) as a potential preventive treatment for migraines in pediatric patients, pediatricians should address the following points with parents:
- Overview of CoQ10: Coenzyme Q10 is an antioxidant that plays a role in energy production within cells. Some studies suggest that it may help reduce the frequency and severity of migraines in children.
- Safety Profile: CoQ10 is generally considered safe for pediatric patients, with few reported side effects. The overall excellent safety profile makes it a viable option for families interested in non-pharmacologic treatments.
- Evidence: Mixed– Research on the effectiveness of CoQ10 for migraine prevention presents mixed results. While some studies indicate positive outcomes, others show limited benefit. It’s important for parents to understand that individual responses may vary.
- Benefit vs Risk: For families who prefer to explore non-drug options first, trying CoQ10 can be a reasonable choice. Given its safety profile, the potential benefits of CoQ10 may outweigh the risks for many children.
- Monitoring and Follow-Up: If parents decide to try CoQ10, ongoing monitoring of the child’s response and open communication about any changes in migraine patterns or side effects are essential.
Summary of Evidence for FeverFew in Pediatric Migraine
Feverfew (Tanacetum parthenium) is a herbal remedy traditionally used for migraine prevention, and its use in pediatric migraine management has garnered interest. The evidence surrounding feverfew for migraines in children is still evolving, but here are some key points from recent studies
Butterbur contains active compounds, such as petasin and isopetasin, which are thought to possess anti-inflammatory properties. These compounds may help reduce the frequency and severity of migraine attacks by stabilizing cell membranes and inhibiting the release of inflammatory mediators.
Pothmann et al., (2005): This was a multicenter prospective open label study looking at whether butterbur had potential as a migraine preventative in children and adolescents. 77% of all patients reported a reduction in the frequency of migraine attacks of at least 50%. 91% of patients felt improvement after 4 months of treatment.
Oelkers-Az et al., (2008): This prospective RCT evaluated butterbur and music therapy in the prevention of pediatric migraine. The authors found that Butterbur and music therapy might be superior to placebo for pediatric migraine prophylaxis.
Butterbur is generally considered safe for short-term use in both adults and children, but there are important safety considerations. Some butterbur products contain pyrrolizidine alkaloids (PAs), which can be toxic to the liver and are potentially carcinogenic. It is crucial to use PA-free butterbur extracts to minimize these risks. Healthcare providers should exercise caution when recommending butterbur for pediatric patients and consider alternative treatments with a more established safety profile.
Anderson & Borlak (2019): Anderson and Borlak discussed hepatobiliary events linked to the use of butterbur extracts, specifically Petadolex. They noted that while butterbur is effective for migraine prevention, there have been reports of liver toxicity, which raises concerns about its safety in pediatric patients.
Butterbur shows promise as a preventive treatment for migraines in children, but the evidence is still not robust enough to make strong recommendations. Given it’s potential for liver toxicity, this should be avoided in the pediatric population.
When discussing butterbur as a potential preventive treatment for migraines in pediatric patients, pediatricians should consider the following points in their conversation with parents:
Overview of Butterbur: Butterbur is a herbal supplement that has been studied for its effectiveness in reducing the frequency and severity of migraines. Some research supports its use, but the evidence is mixed, particularly in children.
Safety Profile: Butterbur has a concerning safety profile due to potential liver toxicity associated with certain formulations. However, specific products labeled as “PA-free” (pyrrolizidine alkaloid-free) are available and are considered safer. Mild side effects may include gastrointestinal upset or fatigue.
Evidence: Mixed- While some studies indicate that butterbur can be effective in preventing migraines, others do not show significant benefits. This inconsistency means that results can vary from child to child.
Benefits vs. Risks: For families considering non-pharmacologic options, butterbur may offer potential benefits; however, the risks associated with certain formulations and the mixed evidence regarding its effectiveness should be carefully weighed. It’s essential to use PA-free products to minimize safety concerns.
Monitoring and Follow-Up: If parents choose to try butterbur, regular monitoring of the child’s response and any side effects is crucial. Open communication with the healthcare provider about the child’s progress is important.
Summary of Evidence for Vitamin D in Pediatric Migraine
Vitamin D, often referred to as the “sunshine vitamin,” is a fat-soluble vitamin crucial for calcium absorption, bone health, and immune function. In recent years, emerging evidence has suggested that vitamin D may also play a role in preventing migraines, including in pediatric populations. This summary provides an overview of the current evidence on the use of vitamin D for preventing migraines in children.
Vitamin D’s role in migraine prevention is thought to be linked to several mechanisms:
- Anti-inflammatory Effects: Vitamin D is known to have immunomodulatory and anti-inflammatory properties. Given that inflammation is a key component in migraine pathophysiology, vitamin D may help to reduce the neuroinflammation associated with migraine attacks.
- Calcium Regulation: Vitamin D regulates calcium levels in the brain, and disturbances in calcium channels are believed to contribute to migraine occurrence. By promoting proper calcium homeostasis, vitamin D may reduce the frequency of attacks.
- Serotonin Regulation: Vitamin D influences the synthesis of serotonin, a neurotransmitter involved in the migraine process. Adequate vitamin D levels may help stabilize serotonin levels, reducing the likelihood of migraine onset.
- Migraine Triggers: Vitamin D deficiency has been linked to various migraine triggers, including poor sleep, fatigue, and stress. By addressing deficiency, vitamin D may help prevent some of these common triggers from leading to a migraine.
- Engula et el.,(2022): This study aimed to determine the levels of vitamin D associated with severity of headaches in pediatric patients with migraine. They found that as the level of vitamin D decreased, the severity of headache increased.
- Kilic et al., (2019): The aim of this retrospective study was to investigate whether pediatric migraine was associated with Vitamin D deficiency and the effect of vitamin D therapy on the frequency, duration, and severity of migraine attacks. The authors concluded that vitamin D supplementation can improve the quality of life of pediatric patients who suffer from migraine. Of note, the treatment group was treated with 2000IU of Vitamin d for 2 months and 600-1000IU of maintenance therapy for 6 months.
- Elmala et el, (2022): This double-blinded prospective clinical trial set out to determine the effects of Vitamin D3 supplementation in children taking Topiramate for pediatric migraine. The authors concluded that vitamin D supplementation (5000IU daily x 4 months) with Topiramate was more effective than Topiramate alone in decreasing frequency and disability from migraine.
- Dell’Isola et al., (2021): This review aimed to summarize the data to determine if vitamin D supplementation prevented primary headache in both adults and children. The authors found that studies point towards a correlation between vitamin D deficiency and increased risk of headache and data analysis reveals that vitamin D supplementation appears to be related to improvement in symptoms, however more studies are needed.
Vitamin D supplementation is generally considered safe when used within recommended dosages. High doses of vitamin D can lead to toxicity, which may cause hypercalcemia (elevated calcium levels), kidney damage, and bone pain. However, these effects are typically seen with doses well above the recommended daily intake.
Vitamin D supplementation shows promise as a preventive treatment for pediatric migraines, particularly in children with vitamin D deficiency. Clinical studies indicate that correcting vitamin D deficiency can lead to a reduction in the frequency and severity of migraines, improved sleep quality, and better overall health. The evidence supporting its efficacy is promising, but more large-scale randomized controlled trials are needed to confirm the optimal dosage, duration, and long-term safety of vitamin D for migraine prevention in children.Given its low cost, safety profile, and additional health benefits, vitamin D supplementation could be a valuable option, particularly for children with low vitamin D levels or those at risk for deficiency.
- When discussing vitamin D as a potential preventive treatment for migraines in pediatric patients, pediatricians should consider the following points in their conversation with parents:
- Overview of Vitamin D: Vitamin D is essential for bone health, immune function, and other metabolic processes. Adequate levels of vitamin D have also been linked to a lower frequency of migraines and headaches, particularly in children who are deficient in this nutrient.
- Safety Profile: Vitamin D is safe for most children when taken at appropriate doses. While high doses can cause toxicity, this is rare and can be avoided with proper dosing. Vitamin D toxicity can lead to elevated calcium levels, which can have serious health effects, but these risks are easily managed with correct supplementation.
- Evidence: While several studies show that correcting vitamin D deficiency can reduce migraine frequency and severity, more research is needed to determine the most effective dosing strategies. Currently, the evidence is promising, especially for children with low vitamin D levels.
- Benefits vs. Risks: The benefits of vitamin D supplementation in reducing migraine frequency and improving overall health may outweigh the risks, especially for children with a documented deficiency. However, parents should be aware that not all children with migraines will respond to vitamin D supplementation, and individual response may vary.
Having a medication that combines riboflavin, magnesium, and coenzyme Q10 for pediatric migraines offers several significant benefits for families managing this condition. One of the primary advantages is convenience; families often find it challenging to track down individual supplements for each ingredient, and a single combination medication simplifies the process.
Additionally, finding the right dosage for each nutrient can be complex, particularly for children. A combination medication ensures that the dosages are pre-calibrated and optimized for efficacy, reducing the risk of under- or overdosing. A single formulation is also more likely to encourage adherence to the treatment plan, making it easier for parents to ensure their child receives the necessary nutrients consistently.
Moreover, riboflavin, magnesium, and coenzyme Q10 each play distinct roles in energy metabolism and neurological function. When combined, they may provide synergistic benefits that enhance their overall effectiveness in reducing migraine frequency and severity.
While there is some data in the adult literature suggesting that this combination can be effective, it’s important to note that it has yet to be extensively studied in pediatric populations. The positive outcomes observed in adults provide a promising foundation, but more research is needed to determine overall efficacy for children.
- Gual et al., (2015): This multi-center RCT aimed to evaluate the efficacy of a nutritional supplement containing magnesium, riboflavin, and Q10 for migraine prevention in adults. The authors concluded that this combination supplement significantly decreased migraine symptoms and burden of disease, compared with placebo.
- Guilbot et al., (2017): This prospective observational study looked at a combination of CoEnzyme Q, feverfew, and magnesium for migraine prophylaxis in adults. Supplementation significantly reduced the number of days with migraine headache during the 3rd month of supplementation. The decrease was progressive over the supplementation period and significant from the first month. 75% of patients reported a 50% reduction in the number of migraine days after 3 months.
Conclusion
In conclusion, riboflavin, magnesium, coenzyme Q10, and Vitamin D are the most promising options for preventing pediatric migraines, particularly due to their favorable safety profiles. Despite mixed data, these treatments may yield positive outcomes, making them appealing alternatives for families seeking non-pharmacologic solutions to manage their child’s migraines. While feverfew and butterbur offer potential benefits, their lack of evidence and safety profiles render them less desirable options.
Other Resources:
Texas Children’s Hospital: Dietary Supplements and Nutraceuticals for Children with MIgraines
Newsletter
Don’t miss a thing! Stay up to date with our latest parenting tips and child health info, new product launches, and exclusive offers.